Sowell Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sowell Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$540K	Buy	+2,239	New	+$491K	0.02%	620
2021 Q2	–	Sell	-259	Closed	-$45K	–	1657
2021 Q1	$45K	Buy	259 +116	+81%	+$19.1K	﹤0.01%	1701
2020 Q4	$24K	Buy	143 +100	+233%	+$14.9K	﹤0.01%	1656
2020 Q3	$6K	Hold	43	–	–	﹤0.01%	1948
2020 Q2	$5K	Hold	43	–	–	﹤0.01%	1897
2020 Q1	$4K	Sell	43 -12	-22%	-$1.55K	﹤0.01%	1900
2019 Q4	$8K	Buy	55 +12	+28%	+$1.63K	﹤0.01%	1758
2019 Q3	$6K	Buy	+43	New	+$5.76K	﹤0.01%	1692

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sowell Financial Services's JAZZ Position: Q2 2026 in Review

Sowell Financial Services opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,239 shares worth $540K. The stake represents 0.02% of the portfolio and ranks #620 among its holdings. This is a return to the name: Sowell Financial Services previously reported a position in JAZZ as recently as Q1 2021.

Sowell Financial Services first reported a position in JAZZ in Q3 2019 and has held it in 8 quarters since. 643 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Sowell Financial Services held 2,239 shares of Jazz Pharmaceuticals worth $540K as of Q2 2026.
Jazz Pharmaceuticals was a new Sowell Financial Services position in Q2 2026.
Jazz Pharmaceuticals made up 0.02% of Sowell Financial Services's portfolio in Q2 2026, its #620 holding.
Sowell Financial Services first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 8 quarters since.
643 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.